Eva Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Eva Sharma has a total of 294 co-authors. Here are the top co-authors by number of shared publications:
- Heather L. Kimmel
National Institute on Drug Abuse, National Institutes of Health , Bethesda, MD
66 shared publications - Cassandra A. Stanton
Behavioral Health and Health Policy Practice, Westat Inc, Rockville, Maryland, USA
59 shared publications - Kathryn C. Edwards
Westat Inc , Rockville, MD
56 shared publications - Maciej Lukasz Goniewicz
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
52 shared publications - Dorothy K. Hatsukami
Masonic Cancer Center University of Minnesota Minneapolis MN USA
48 shared publications - Andrew Hyland
Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
46 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 12 (September) , 1-13
Predictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) Study, 2014/15-2021
Introduction: E-cigarettes have increased in use prevalence among adults who smoke cigarettes. However, the population-based literature on e-cigarette use and smoking cessation largely still focuses on those planning or attempting to quit smoking. We evaluated predictors of cigarette...
- 30 September 2026
- Published by European Publishing in Tobacco Prevention & Cessation
- Vol. 12 (September) , 1-13
Open AccessPredictors of cigarette discontinuation and reduction among adults never planning to quit smoking: Longitudinal findings from the U.S. Population Assessment of Tobacco and Health (PATH) Study, 2014/15-2021
Introduction: E-cigarettes have increased in use prevalence among adults who smoke cigarettes. However, the population-based literature on e-cigarette use and smoking cessation largely still focuses on those planning or attempting to quit smoking. We evaluated predictors of cigarette...
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 2 provides demographic and tobacco use characteristics of any tobacco users.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 2 provides demographic and tobacco use characteristics of any tobacco users.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 5 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 5 provides Wave 1 and Wave 4 cotinine cut-points for any tobacco use.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 5 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 5 provides Wave 1 and Wave 4 cotinine cut-points for any tobacco use.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Figure 1 shows the analytic sample flow chart.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Figure 1 shows the analytic sample flow chart.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 1 provides demographic and tobacco use characteristics of exclusive and polytobacco users.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 1 provides demographic and tobacco use characteristics of exclusive and polytobacco users.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 6 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 6 provides Wave 1 and Wave 4 TNE-2 cut-points for any tobacco use.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 6 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 6 provides Wave 1 and Wave 4 TNE-2 cut-points for any tobacco use.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 3 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 3 provides prevalence rates of any tobacco use using cotinine cut-points.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 3 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 3 provides prevalence rates of any tobacco use using cotinine cut-points.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplemental Table 4 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 4 provides prevalence rates of any tobacco use using TNE-2 cut-points.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 4 from Validating Wave 1 (2014) Urinary Cotinine and TNE-2 Cut-points for Differentiating Wave 4 (2017) Cigarette Use from Non-use in the United States Using Data from the PATH Study
Supplemental Table 4 provides prevalence rates of any tobacco use using TNE-2 cut-points.
- 7 May 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (10) , 1764-1770
Impact of prepregnancy menthol cigarette use on smoking cessation across pregnancy and postpartum: a longitudinal analysis of the Population Assessment of Tobacco and Health (PATH) Study
The purpose of this study was to characterize smoking cessation at pregnancy and postpartum return to use as a function of pre-pregnancy menthol vs. non-menthol cigarette use. Data were drawn from Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study, using three longitudinal time-points indicating pre-pregnancy, pregnancy, and postpartum in 179 participants who reported exclusive cigarette smoking at pre-pregnancy and were currently pregnant during the middle interval. Outcomes included (1) quit attempts and successful quitting within 12 months of pregnancy change in past 30-day smoking frequency at pregnancy, and postpartum return to use. Generalized estimating equations were conducted adjusting for sociodemographic and smoking characteristics. Approximately 47% of pregnant persons who smoked reported use of menthol cigarettes at pre-pregnancy, almost 80% attempted to quit/cut down during pregnancy, and 43.6% successfully quit. Approximately 56% of those who reported being quit at pregnancy returned to use in postpartum. Menthol use was associated with smoking on 1.13 fewer days among those who continued to smoke at pregnancy. Although pre-pregnancy menthol cigarette use was associated with greater nicotine dependence (fewer minutes to first cigarette; p < .05), menthol cigarette use was not significantly associated with quit attempts, successful cessation or changes in smoking frequency at pregnancy, or postpartum return to use (ps > .05). Our study did not find an impact of pre-pregnancy menthol cigarette use on quit attempts, cessation, or postpartum return to use. Findings suggest cessation efforts should focus on behavioral and contextual factors beyond cigarette mentholation alone.
- 7 May 2026
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 28 (10) , 1764-1770
Impact of prepregnancy menthol cigarette use on smoking cessation across pregnancy and postpartum: a longitudinal analysis of the Population Assessment of Tobacco and Health (PATH) Study
The purpose of this study was to characterize smoking cessation at pregnancy and postpartum return to use as a function of pre-pregnancy menthol vs. non-menthol cigarette use. Data were drawn from Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study, using three longitudinal time-points indicating pre-pregnancy, pregnancy, and postpartum in 179 participants who reported exclusive cigarette smoking at pre-pregnancy and were currently pregnant during the middle interval. Outcomes included (1) quit attempts and successful quitting within 12 months of pregnancy change in past 30-day smoking frequency at pregnancy, and postpartum return to use. Generalized estimating equations were conducted adjusting for sociodemographic and smoking characteristics. Approximately 47% of pregnant persons who smoked reported use of menthol cigarettes at pre-pregnancy, almost 80% attempted to quit/cut down during pregnancy, and 43.6% successfully quit. Approximately 56% of those who reported being quit at pregnancy returned to use in postpartum. Menthol use was associated with smoking on 1.13 fewer days among those who continued to smoke at pregnancy. Although pre-pregnancy menthol cigarette use was associated with greater nicotine dependence (fewer minutes to first cigarette; p < .05), menthol cigarette use was not significantly associated with quit attempts, successful cessation or changes in smoking frequency at pregnancy, or postpartum return to use (ps > .05). Our study did not find an impact of pre-pregnancy menthol cigarette use on quit attempts, cessation, or postpartum return to use. Findings suggest cessation efforts should focus on behavioral and contextual factors beyond cigarette mentholation alone.
- Open Access
- 9 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0338007
Disposal practices of cigarettes and electronic nicotine products among adults, findings from Wave 6 (2021) of the PATH Study
Background: Tobacco product waste is environmentally hazardous but preventable. Therefore, it is important to understand tobacco disposal behaviors among those using tobacco products. Objectives: To explore self-reported disposal practices of cigarette butts and electronic nicotine products (ENP) components among adults (aged 18+). Methods: We used nationally representative cross-sectional data from Wave 6 (2021; n = 29,516) of the Population Assessment of Tobacco and Health (PATH) Study among adults who used cigarettes (manufactured and/or roll-your-own) and/or ENP every day, some days, or in the past 30 days. Results: In 2021, 89.7% (95% CI: 88.7, 90.6) of adults who smoked manufactured cigarettes usually disposed of cigarette butts in landfills (in an ash tray, in a cigarette disposal, or in the trash). Most adults who usually disposed of butts in landfills smoked daily (73.1%; 95% CI: 71.3, 74.9) and smoked an average of 14.6 cigarettes per day. Among those who used ENP, most adults usually disposed of the components in landfills (disposable devices: 83.1%; 95% CI: 80.5, 85.4; empty pods and cartridges: 85.4%; 95% CI: 82.4, 87.9; coils and atomizers: 71.2%; 95% CI: 68.1, 74.1; batteries: 48.5%; 95% CI: 45.2, 51.9; e-liquid containers: 70.9%; 95% CI: 67.1, 74.5; and leftover or unused e-liquid: 50.5%; 95% CI: 45.8, 55.2). Recycling as a usual practice was limited for people who used ENP- for disposable devices: 6.0% (95%CI: 4.6, 7.8); empty pods and cartridges: 5.0% (95% CI: 3.7, 6.8); coils and atomizers: 11.7% (95% CI: 9.4, 14.5); batteries: 23.7% (95% CI: 20.9, 26.8); and e-liquid containers: 18.0% (95% CI: 15.1, 21.3). Discussion: These findings demonstrate the large scope of tobacco product waste disposal in the United States and may inform efforts to address tobacco product waste management, such as environmental impact assessments and consumer education about proper disposal of tobacco products.
- 9 December 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (12) , e0338007
Open AccessDisposal practices of cigarettes and electronic nicotine products among adults, findings from Wave 6 (2021) of the PATH Study
Background: Tobacco product waste is environmentally hazardous but preventable. Therefore, it is important to understand tobacco disposal behaviors among those using tobacco products. Objectives: To explore self-reported disposal practices of cigarette butts and electronic nicotine products (ENP) components among adults (aged 18+). Methods: We used nationally representative cross-sectional data from Wave 6 (2021; n = 29,516) of the Population Assessment of Tobacco and Health (PATH) Study among adults who used cigarettes (manufactured and/or roll-your-own) and/or ENP every day, some days, or in the past 30 days. Results: In 2021, 89.7% (95% CI: 88.7, 90.6) of adults who smoked manufactured cigarettes usually disposed of cigarette butts in landfills (in an ash tray, in a cigarette disposal, or in the trash). Most adults who usually disposed of butts in landfills smoked daily (73.1%; 95% CI: 71.3, 74.9) and smoked an average of 14.6 cigarettes per day. Among those who used ENP, most adults usually disposed of the components in landfills (disposable devices: 83.1%; 95% CI: 80.5, 85.4; empty pods and cartridges: 85.4%; 95% CI: 82.4, 87.9; coils and atomizers: 71.2%; 95% CI: 68.1, 74.1; batteries: 48.5%; 95% CI: 45.2, 51.9; e-liquid containers: 70.9%; 95% CI: 67.1, 74.5; and leftover or unused e-liquid: 50.5%; 95% CI: 45.8, 55.2). Recycling as a usual practice was limited for people who used ENP- for disposable devices: 6.0% (95%CI: 4.6, 7.8); empty pods and cartridges: 5.0% (95% CI: 3.7, 6.8); coils and atomizers: 11.7% (95% CI: 9.4, 14.5); batteries: 23.7% (95% CI: 20.9, 26.8); and e-liquid containers: 18.0% (95% CI: 15.1, 21.3). Discussion: These findings demonstrate the large scope of tobacco product waste disposal in the United States and may inform efforts to address tobacco product waste management, such as environmental impact assessments and consumer education about proper disposal of tobacco products.